Teva, Medicis Cease Legal Battle Over Solodyn
March 20, 2009 (FinancialWire) -- Medicis (NYSE: MRX) and Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) have agreed to terminate all legal disputes between them relating to SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets. </p>…